Got a News Tip for NaturalNews? Send us your news tip, and we'll investigate!

J&J Settles Risperdal Cases for $181 Million

Posted: August 31, 2012 |   Comments

CHICAGO (CN) - Thirty-six states will split $181 million from Janssen Pharmaceuticals and Johnson & Johnson, which were accused of pushing the schizophrenia drug Risperdal for off-label uses.

Doctors are allowed to prescribe drugs for off-label uses, but drug companies cannot push the drugs for that.

Janssen's corporate parent Johnson & Johnson did not admit it did anything wrong.

States settled for varying amounts. According to the lawsuits in the Courthouse News database, Illinois sought $50,000 for each consumer law and/or deceptive trade violation; Oregon sought $25,000 per violation, Texas $20,000 per violation, Delaware and Hawaii $10,000 per violation, Alabama $2,000 per violation.

Read more here:

Have a Comment? Share it...

comments powered by Disqus